What’s next for biopharma? To find out, is having a global conversation about the future of the industry. We started with insights from 254 executives, and now we’re digging deeper into the new geographies, pipelines, and barriers that will shape tomorrow’s biopharma.
What will the next insight be, and what will it mean for you? Explore the latest findings and discover new voices as you Go Beyond Today’s Biopharma.
Which risks are top-of-mind for biopharma executives? And what are they doing about them? Take a look at the answers from 254 leaders in biopharma with The Changing Biopharma Risk Equation, an independent survey and analysis produced by the Economist Intelligence Unit, and companion data visualization.